Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 17.39 CNY -1.75% Market Closed
Market Cap: 16.7B CNY
Have any thoughts about
Zhejiang Medicine Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Zhejiang Medicine Co Ltd stock under the Base Case scenario is 15.78 CNY. Compared to the current market price of 17.39 CNY, Zhejiang Medicine Co Ltd is Overvalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15.78 CNY
Overvaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Zhejiang Medicine Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Zhejiang Medicine Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Zhejiang Medicine Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Zhejiang Medicine Co Ltd

Provide an overview of the primary business activities
of Zhejiang Medicine Co Ltd.

What unique competitive advantages
does Zhejiang Medicine Co Ltd hold over its rivals?

What risks and challenges
does Zhejiang Medicine Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zhejiang Medicine Co Ltd.

Provide P/S
for Zhejiang Medicine Co Ltd.

Provide P/E
for Zhejiang Medicine Co Ltd.

Provide P/OCF
for Zhejiang Medicine Co Ltd.

Provide P/FCFE
for Zhejiang Medicine Co Ltd.

Provide P/B
for Zhejiang Medicine Co Ltd.

Provide EV/S
for Zhejiang Medicine Co Ltd.

Provide EV/GP
for Zhejiang Medicine Co Ltd.

Provide EV/EBITDA
for Zhejiang Medicine Co Ltd.

Provide EV/EBIT
for Zhejiang Medicine Co Ltd.

Provide EV/OCF
for Zhejiang Medicine Co Ltd.

Provide EV/FCFF
for Zhejiang Medicine Co Ltd.

Provide EV/IC
for Zhejiang Medicine Co Ltd.

Show me price targets
for Zhejiang Medicine Co Ltd made by professional analysts.

What are the Revenue projections
for Zhejiang Medicine Co Ltd?

How accurate were the past Revenue estimates
for Zhejiang Medicine Co Ltd?

What are the Net Income projections
for Zhejiang Medicine Co Ltd?

How accurate were the past Net Income estimates
for Zhejiang Medicine Co Ltd?

What are the EPS projections
for Zhejiang Medicine Co Ltd?

How accurate were the past EPS estimates
for Zhejiang Medicine Co Ltd?

What are the EBIT projections
for Zhejiang Medicine Co Ltd?

How accurate were the past EBIT estimates
for Zhejiang Medicine Co Ltd?

Compare the revenue forecasts
for Zhejiang Medicine Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zhejiang Medicine Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zhejiang Medicine Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zhejiang Medicine Co Ltd compared to its peers.

Compare the P/E ratios
of Zhejiang Medicine Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Zhejiang Medicine Co Ltd with its peers.

Analyze the financial leverage
of Zhejiang Medicine Co Ltd compared to its main competitors.

Show all profitability ratios
for Zhejiang Medicine Co Ltd.

Provide ROE
for Zhejiang Medicine Co Ltd.

Provide ROA
for Zhejiang Medicine Co Ltd.

Provide ROIC
for Zhejiang Medicine Co Ltd.

Provide ROCE
for Zhejiang Medicine Co Ltd.

Provide Gross Margin
for Zhejiang Medicine Co Ltd.

Provide Operating Margin
for Zhejiang Medicine Co Ltd.

Provide Net Margin
for Zhejiang Medicine Co Ltd.

Provide FCF Margin
for Zhejiang Medicine Co Ltd.

Show all solvency ratios
for Zhejiang Medicine Co Ltd.

Provide D/E Ratio
for Zhejiang Medicine Co Ltd.

Provide D/A Ratio
for Zhejiang Medicine Co Ltd.

Provide Interest Coverage Ratio
for Zhejiang Medicine Co Ltd.

Provide Altman Z-Score Ratio
for Zhejiang Medicine Co Ltd.

Provide Quick Ratio
for Zhejiang Medicine Co Ltd.

Provide Current Ratio
for Zhejiang Medicine Co Ltd.

Provide Cash Ratio
for Zhejiang Medicine Co Ltd.

What is the historical Revenue growth
over the last 5 years for Zhejiang Medicine Co Ltd?

What is the historical Net Income growth
over the last 5 years for Zhejiang Medicine Co Ltd?

What is the current Free Cash Flow
of Zhejiang Medicine Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zhejiang Medicine Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zhejiang Medicine Co Ltd

Current Assets 5.7B
Cash & Short-Term Investments 1.8B
Receivables 1.8B
Other Current Assets 2B
Non-Current Assets 7.2B
Long-Term Investments 247.4m
PP&E 6.1B
Intangibles 728.1m
Other Non-Current Assets 83.9m
Current Liabilities 2.1B
Accounts Payable 1.1B
Accrued Liabilities 142.4m
Short-Term Debt 270.9m
Other Current Liabilities 627.8m
Non-Current Liabilities 801.1m
Long-Term Debt 424.5m
Other Non-Current Liabilities 376.6m
Efficiency

Earnings Waterfall
Zhejiang Medicine Co Ltd

Revenue
8.3B CNY
Cost of Revenue
-5.6B CNY
Gross Profit
2.7B CNY
Operating Expenses
-2.5B CNY
Operating Income
192.4m CNY
Other Expenses
280.3m CNY
Net Income
472.7m CNY

Free Cash Flow Analysis
Zhejiang Medicine Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Zhejiang Medicine Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Negative 3-Years Revenue Growth
48/100
Profitability
Score

Zhejiang Medicine Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Zhejiang Medicine Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
High Altman Z-Score
Negative Net Debt
76/100
Solvency
Score

Zhejiang Medicine Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Zhejiang Medicine Co Ltd

Wall Street analysts forecast Zhejiang Medicine Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Medicine Co Ltd is 18.36 CNY with a low forecast of 18.18 CNY and a high forecast of 18.9 CNY.

Lowest
Price Target
18.18 CNY
5% Upside
Average
Price Target
18.36 CNY
6% Upside
Highest
Price Target
18.9 CNY
9% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Zhejiang Medicine Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Zhejiang Medicine Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

16.7B CNY

Dividend Yield

0%

Description

Zhejiang Medicine Co., Ltd. engages in the production and sale of pharmaceutical products. The company is headquartered in Shaoxing, Zhejiang and currently employs 5,901 full-time employees. The firm mainly provides nourishments for animals and human, health care products, and chemicals and chemical raw materials, among others. The firm's products include synthetic vitamin E, natural vitamin E soft capsules, Beta carotene, vancomycin hydrochloride for injection and teicoplanin for injection, among others. The firm distributes its products within domestic market and to overseas markets.

Contact

ZHEJIANG
Shaoxing
No. 168 Zhiyuanzhong Avenue, Binhai Xincheng
+8657585211969
www.zmc.top

IPO

1999-10-21

Employees

5 901

Officers

President & Vice Chairman
Mr. Chun Lei Lu
Executive Vice President
Mr. Hongwei Wang
Vice President
Mr. Jianhong Ping
Senior Manager
Mr. Xiaoping Wang
Vice Chairman & Vice President
Mr. Nan Xing Li
CFO & Financial Director
Ms. Qirong Li
Show More
Accounting Supervisor
Guangshan Guo
Show Less

See Also

Discover More
What is the Intrinsic Value of one Zhejiang Medicine Co Ltd stock?

The intrinsic value of one Zhejiang Medicine Co Ltd stock under the Base Case scenario is 15.78 CNY.

Is Zhejiang Medicine Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17.39 CNY, Zhejiang Medicine Co Ltd is Overvalued by 9%.

Back to Top